Clinical Trial Update: Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of bendamustine hydrochloride combined with lenalidomide and dexamethasone for relapsed/refractory multiple myeloma has completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bendamustine Hydrochloride (bendamustine)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-03-30